Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J V Lucey

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
The Journal of Clinical Psychiatry|February 24, 2001
Intramuscular ziprasidone compared with intramuscular haloperidol in the treatment of acute psychosis. Ziprasidone I.M. Study GroupS Brook, J V Lucey, K P Gunn
The American Journal of Psychiatry|November 1, 1994
Central serotonergic hyperresponsivity in late-onset Alzheimer's diseaseD M McLoughlin, J V Lucey, T G Dinan
Psychological Medicine|March 1, 1996
Serotonin activity in anorexia nervosa after long-term weight restoration: response to D-fenfluramine challengeA M O'Dwyer, J V Lucey, G F Russell
The British Journal of Psychiatry : the Journal of Mental Science|February 1, 1997
Enhanced growth hormone responses to pyridostigmine challenge in patients with panic disorderJ M Cooney, J V Lucey, T G Dinan
Biological Psychiatry|August 15, 1991
Effect of fluoxetine on noradrenergic mediated growth hormone release: a double blind, placebo-controlled studyK O'Flynn, V O'Keane, J V Lucey, et al.
The American Journal of Psychiatry|June 10, 1998
Neuroendocrine evidence that clozapine's serotonergic antagonism is relevant to its efficacy in treating hallucinations and other positive schizophrenic symptomsH Jones, V A Curtis, P Wright, et al.
International Clinical Psychopharmacology|November 17, 1998
Risperidone is associated with blunting of D-fenfluramine evoked serotonergic responses in schizophreniaH Jones, V A Curtis, P A Wright, et al.
Acta Psychiatrica Scandinavica|November 1, 1992
The desipramine-induced growth hormone response and the dexamethasone suppression test in obsessive-compulsive disorderJ V Lucey, S Barry, M G Webb, et al.
The American Journal of Psychiatry|June 1, 1993
Elevated growth hormone responses to pyridostigmine in obsessive-compulsive disorder: evidence of cholinergic supersensitivityJ V Lucey, G Butcher, A W Clare, et al.
International Clinical Psychopharmacology|January 1, 1992
Buspirone induced prolactin responses in obsessive-compulsive disorder (OCD): is OCD a 5-HT2 receptor disorder?J V Lucey, G Butcher, A W Clare, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
The Journal of Clinical Psychiatry|February 24, 2001
Intramuscular ziprasidone compared with intramuscular haloperidol in the treatment of acute psychosis. Ziprasidone I.M. Study GroupS Brook, J V Lucey, K P Gunn
The American Journal of Psychiatry|November 1, 1994
Central serotonergic hyperresponsivity in late-onset Alzheimer's diseaseD M McLoughlin, J V Lucey, T G Dinan
Psychological Medicine|March 1, 1996
Serotonin activity in anorexia nervosa after long-term weight restoration: response to D-fenfluramine challengeA M O'Dwyer, J V Lucey, G F Russell
The British Journal of Psychiatry : the Journal of Mental Science|February 1, 1997
Enhanced growth hormone responses to pyridostigmine challenge in patients with panic disorderJ M Cooney, J V Lucey, T G Dinan
Biological Psychiatry|August 15, 1991
Effect of fluoxetine on noradrenergic mediated growth hormone release: a double blind, placebo-controlled studyK O'Flynn, V O'Keane, J V Lucey, et al.
The American Journal of Psychiatry|June 10, 1998
Neuroendocrine evidence that clozapine's serotonergic antagonism is relevant to its efficacy in treating hallucinations and other positive schizophrenic symptomsH Jones, V A Curtis, P Wright, et al.
International Clinical Psychopharmacology|November 17, 1998
Risperidone is associated with blunting of D-fenfluramine evoked serotonergic responses in schizophreniaH Jones, V A Curtis, P A Wright, et al.
Acta Psychiatrica Scandinavica|November 1, 1992
The desipramine-induced growth hormone response and the dexamethasone suppression test in obsessive-compulsive disorderJ V Lucey, S Barry, M G Webb, et al.
The American Journal of Psychiatry|June 1, 1993
Elevated growth hormone responses to pyridostigmine in obsessive-compulsive disorder: evidence of cholinergic supersensitivityJ V Lucey, G Butcher, A W Clare, et al.
International Clinical Psychopharmacology|January 1, 1992
Buspirone induced prolactin responses in obsessive-compulsive disorder (OCD): is OCD a 5-HT2 receptor disorder?J V Lucey, G Butcher, A W Clare, et al.
Pageof 4